Search Results
Oct 30, 2025, 09:00 ET Relevance Ventures Named to Inc.'s 2025 List of Founder‑Friendly Investors for the Fourth Year in a Row
investors who offer more than just financial backing—those who bring mentorship, resources, and a true spirit of partnership to your growth journey—is both rare and invaluable," says Bonny Ghosh, editorial director at Inc. "The 2025 Founder-Friendly Investors are collaborators and dedicated to helping their
More news about: Relevance Ventures
Oct 30, 2025, 09:00 ET Concord Energy Strategies Engages Former U.S. Treasury Senior Advisor as a Senior Strategic Advisor for Concord's Clean Energy Tax Credit Compliance Solutions
ventures. Dennis Stilger Jr., Founder and Managing Director of Concord, commented, "Matt is one of the rare people who helped shape the implementation of the largest clean energy investments in history, and can explain it to you in plain English. His expertise
More news about: Concord Energy Strategies, LLC
Oct 30, 2025, 08:55 ET NYSE Content Advisory: Pre-Market Update + Fortune Celebrates Cyber 60 List
President Trump and his Chinese counterpart met overnight in South Korea. Among the headlines, China will pause export controls over rare earths, while the U.S. will cut fentanyl-linked tariffs. Opening
More news about: New York Stock Exchange
Oct 30, 2025, 08:52 ET Global Location Strategies Report: $350 Billion U.S. Pharmaceutical Manufacturing Investment Boom Challenged by Labor Shortages, Tariffs and Policy Shifts
medicines made from living cells or organisms that can treat conditions that were once very difficult to manage, such as cancers, autoimmune disorders, and rare genetic diseases. The findings reveal that a current $350 billion investment boom is being constrained not by cost, but by talent. Skilled labor shortages
More news about: Global Location Strategies
Oct 30, 2025, 08:43 ET Two-Day Online Auction by Tiger Group Features Battery Manufacturing and Lab Equipment from Natron Energy
Jonathan Holiday. "The availability of this immaculate equipment is a rare opportunity." Bidding in the
More news about: Tiger Group
Oct 30, 2025, 08:42 ET Robert Anton Wilson Comes Alive in Award-Winning Biography
bold new voice in American literature, redefining biography with fearless storytelling and intellectual rigor. His book draws on extensive research, rare interviews, and archival materials to trace Wilson's intellectual journey. Chapel Perilous is not just an extraordinary biography; it is a full
More news about: Media Heist Publications
Oct 30, 2025, 08:36 ET Bitcoin Trading Cards Rebrands as Based Trading Cards, Signaling New Era for Collectible Innovation
COMC. Standout sales include a Silk Road Founder Card selling for 0.41 BTC, an Orange Pill in a Box S1 box going for 0.27 BTC ($29,000), and rare Greg Foss and Tone Vays cards fetching 0.26 BTC each. These milestones underscore the brand's surging global demand and growing reputation as
More news about: Based Trading Cards
Oct 30, 2025, 08:32 ET Baltimore Entrepreneurs Invited to "Step Inside" EO for a Day of Real Stories, Big Ideas, and Raw Leadership Lessons
Organization (EO) Baltimore Chapter on Thursday, November 13. The free event, held at The Pendry Baltimore's Waterfront Room, offers a rare inside look at how EO supports entrepreneurs through candid storytelling, peer-to-peer learning, and a thriving local community.
More news about: Entrepreneurs' Organization Baltimore
Oct 30, 2025, 08:00 ET Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025
hospitalization.5 HRS is estimated to affect more than 60,000 Americans annually, approximately 0.01% of the U.S. population,6 making it a rare condition; and rates of HRS hospitalizations are increasing.7 Please see Limitation of Use and
More news about: Mallinckrodt plc
Oct 30, 2025, 08:00 ET LG PARTNERS WITH EXPERT CRAFTSMAN CHIP WADE TO SHOWCASE INNOVATION IN LUXURY TREEHOUSE VACATION RENTAL
excellence with high performance," said Chip Wade, owner and designer of Wade Works Creative. The event will give guests and media a rare, up-close look at how thoughtful design and high-performance appliances come together to redefine modern living in one of the most serene settings imaginable.
More news about: LG Electronics USA
Oct 30, 2025, 07:30 ET Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
translated well in the human setting. Uninjected tumors shrinking from a locally administered therapy, referred to as abscopal effects, are generally rare for local therapies. Yet, an abscopal effect was observed in at least 20% of 48 patients who received drug volumes above 40% of their tumor burden.
More news about: Intensity Therapeutics Inc.
Oct 30, 2025, 07:05 ET REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment
More news about: REGENXBIO Inc.
Oct 30, 2025, 07:00 ET Congebec Appoints Tim Ludwig as Chief Commercial Officer
With more than 25 years in the food processing and logistics industry, Tim Ludwig brings a rare combination of hands-on operational insight and visionary leadership. He is best known as the founder of Bradner Cold Storage, which he launched in
More news about: Congébec Logistique Inc.
Oct 30, 2025, 07:00 ET Peabody Reports Results For Quarter Ended September 30, 2025
the One Big Beautiful Bill Act passed in July. Peabody is progressing its PRB rare earth initiative, and in coming months intends to advance the characterization of rare earth elements and critical minerals in its feedstock, continue discussions with the U.S. administration
More news about: Peabody
Oct 30, 2025, 07:00 ET Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
treatment of patients with pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease (PH-ILD), and other rare and serious pulmonary disorders. TPIP is administered in a capsule-based inhalation device. TPIP is an investigational drug product that has not been
More news about: Insmed Incorporated
Oct 30, 2025, 06:59 ET Comic Book Market to Reach $16.8 Billion by 2024 in short term and $31.2 Billion by 2034 Globally, at 6.6% CAGR: Allied Market Research
• Rise of collector interest in rare and vintage comics
More news about: Allied Market Research
Oct 30, 2025, 06:30 ET High Purity Gas Market is expected to reach $52.78 billion by 2030 - Exclusive Report by MarketsandMarkets™
Air separation technology is the most cost-effective technology used to produce ultra-high purity (UHP) nitrogen, oxygen, or "rare gases" like neon, krypton, and xenon. There are two methods for air separation: cryogenic separation and non-cryogenic separation. Cryogenic separation
More news about: MarketsandMarkets
Oct 30, 2025, 06:00 ET The Cigna Group Reports Strong Third Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook
formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person
More news about: The Cigna Group
Oct 30, 2025, 02:18 ET Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results
commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions. The company has a rich and expanding research and development program based on its proprietary IgG-cleaving enzyme technology
More news about: Hansa Biopharma AB
Oct 30, 2025, 02:16 ET Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results
commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions. The company has a rich and expanding research and development program based on its proprietary IgG-cleaving enzyme technology
More news about: Hansa Biopharma AB
Oct 30, 2025, 01:28 ET Samyang Corporation Showcases Expanded Applications of Its AI-Based Standardized Sugar Reduction Solution at U.S. Food Expo
such as ice cream and sauces, while improving its overall sophistication. Nexweet® Allulose, produced in-house by Samyang, is a rare sugar naturally found in fruits and other foods. It provides approximately 70% of the sweetness of sugar while containing almost zero calories. And
More news about: Samyang Corporation
Oct 29, 2025, 17:00 ET U.S. Strategic Metals Enters Strategic Partnership with Australia's RareX
Minerals and Rare Earths. The MOU establishes a framework for collaboration between USSM and RareX to align rare earth and critical mineral production with multi-metallic downstream processing and supply chain development in the United States focusing on heavy rare earths elements
More news about: US Strategic Metals
Oct 29, 2025, 16:30 ET Tronox Declares Fourth Quarter 2025 Dividend
titanium-bearing mineral sands and operate upgrading facilities that produce high-grade titanium feedstock materials, pig iron and other minerals, including the rare earth-bearing mineral, monazite. With approximately 6,500 employees across six continents, our rich diversity, unmatched vertical integration model,
More news about: Tronox Holdings plc
Oct 29, 2025, 16:05 ET Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2025
of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential
More news about: Viking Therapeutics, Inc.
Oct 29, 2025, 16:02 ET Leica Store & Gallery New York Presents "Within One Breath:" A Solo Exhibition by Matt Draper
Over the past decade, Draper has spent nearly one thousand days documenting the annual migration of humpback whales in the Pacific Islands, capturing rare and previously unrecorded behaviors. Among his most notable works, Bow was selected as the only photograph included on the UNESCO Memory Disc,
More news about: Leica Camera USA